ACTIVE

GSK-PROJECTEN

Export PDF
Financial year 2025 · closed on 30/06/2025
Net result
1,7 k €
-93.5% YoY
Gross margin
12,4 k €
-80.6% YoY
Equity
58,6 k €
+3.1% YoY

What does GSK-PROJECTEN do?

GSK-PROJECTEN is a Private limited company incorporated in 2007. Its main activity is: Development of building projects. Its registered office is in Hasselt.

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0890.187.608
Incorporation
31/05/2007
Legal form
Private limited company
Registered office
Guffenslaan 44
3500 Hasselt · FlandreSee on map
Contributed capital
10 172,50 €
Latest accounts
30/06/2025
Activities (NACE)
41101Development of building projects· main68121Buying and selling of own real estate70111Activities of head offices41102Development of building projects68100Buying and selling of own real estate68110Buying and selling of own real estate+12
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 17 financial years

20252024202320222021202020192018201720162015201420132012201120092008
Income statement
Gross margin12,4 k €63,7 k €23,2 k €42,9 k €22,6 k €20,6 k €21,2 k €2,6 k €11,8 k €-4 k €31,8 k €44,8 k €50,6 k €61,8 k €97,8 k €57,3 k €-10,8 k €
EBITDA11,4 k €63,2 k €22,8 k €40,6 k €20,3 k €18,7 k €18,9 k €325,1 €8,8 k €-7 k €28,8 k €41,4 k €48,5 k €57,9 k €83,9 k €56,9 k €-11,6 k €
Operating result9,6 k €62,1 k €21,7 k €39,4 k €19,2 k €16,6 k €16,5 k €-2 k €6,4 k €-9,5 k €38 €9,6 k €14,9 k €23,6 k €42,4 k €48,7 k €-11,6 k €
Net result1,7 k €26,7 k €8,7 k €53,6 k €24,5 k €20,6 k €22,8 k €80,5 €7 k €71,4 k €-7 k €884,8 €2 k €135,1 €5,2 k €20 k €-27,3 k €
Balance sheet
Equity58,6 k €56,9 k €55,2 k €46,5 k €27,9 k €23,4 k €22,7 k €20 k €19,9 k €18,9 k €12,5 k €19,5 k €18,6 k €16,7 k €16,5 k €11,3 k €-8,7 k €
Total assets66,1 k €310,5 k €385,4 k €222,3 k €181,4 k €177 k €176,1 k €147,8 k €152,5 k €212,6 k €318,3 k €334,1 k €421,5 k €675,8 k €467,6 k €641,3 k €528,7 k €
Cash7,6 k €257,2 k €4 k €3 k €6,3 k €6,1 k €4,2 k €2,9 k €2,1 k €3,8 k €15,3 k €6,4 k €67,5 k €109 k €25,3 k €53 k €15,4 k €
Debts7,5 k €253,7 k €255,6 k €175,8 k €153,6 k €153,6 k €153,4 k €127,9 k €132,6 k €193,7 k €305,8 k €314,6 k €402,8 k €654,5 k €448,4 k €603,2 k €533,7 k €
Estimate

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€
See the valuation
Governance

Board of directors

Seen on filing of 30/06/2025 · 1 active · 4 ended

Active mandates

Gerard Schouten

Director · since 05 juillet 2024

Active

Ended mandates

Gerard Schouten

Manager

Ended
GSK-Beheer

Manager · 0871.717.917

Represented by Gerard Schouten

Ended
GSK-Beheer

Mandate · 0871.717.917

Ended
GSK-Beheer

Director · 0871.717.917

Represented by Gerard Schouten

Ended
At this address

Other companies at this address

CompanyCBE no.
BOUWID● Active
0833.021.152
BRIC architectuur● Active
1014.907.040
GSK-Beheer● Active
0871.717.917
GSK INVESTMENT COMPANY● Active
0883.242.111
TERRA NOVA● Active
1035.421.748
Annual accounts

Full financial information

202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/07/202401/07/202301/07/202201/07/202101/07/202001/07/2019
Closing of the financial year30/06/202530/06/202430/06/202330/06/202230/06/202130/06/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date30/01/202609/01/202511/01/202426/12/202215/12/202130/12/2020
General meeting12/12/202513/12/202408/12/202309/12/202210/12/202111/12/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

17 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model30/06/202512/12/202530/01/2026DutchPDF
Abridged model30/06/202413/12/202409/01/2025DutchPDF
Abridged model30/06/202308/12/202311/01/2024DutchPDF
Abridged model30/06/202209/12/202226/12/2022DutchPDF
Abridged model30/06/202110/12/202115/12/2021DutchPDF
Abridged model30/06/202011/12/202030/12/2020DutchPDF
Abridged model30/06/201913/12/201923/12/2019DutchPDF
Abridged model30/06/201814/12/201801/01/2019DutchPDF
Abridged model30/06/201708/12/201723/12/2017DutchPDF
Abridged model30/06/201609/12/201629/12/2016DutchPDF
Abridged model30/06/201511/12/201522/12/2015DutchPDF
Abridged model30/06/201412/12/201422/12/2014DutchPDF
Abridged model30/06/201313/12/201322/12/2013DutchPDF
Abridged model30/06/201214/12/201203/01/2013DutchPDF
Abridged model30/06/201109/12/201121/12/2011DutchPDF
Abridged model31/12/200911/06/201028/06/2010DutchPDF
Abridged model31/12/200812/06/200922/06/2009DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/06/2025 · 1 active · 4 ended

Active mandates

Gerard Schouten

Director · since 05 juillet 2024

Active

Ended mandates

Gerard Schouten

Manager

Ended
GSK-Beheer

Manager · 0871.717.917

Represented by Gerard Schouten

Ended
GSK-Beheer

Mandate · 0871.717.917

Ended
GSK-Beheer

Director · 0871.717.917

Represented by Gerard Schouten

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates06/08/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates11/03/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates21/01/2021
    ONTSLAGEN - BENOEMINGEN - WIJZIGING RECHTSVORM
    PDF
  • Registered office19/02/2016
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates28/09/2011
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other27/12/2010
    BOEKJAAR
    PDF
  • Registered office28/10/2009
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Other28/06/2007
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 20251,7 k €↓
  2. 2024
    Annual accounts 202426,7 k €↑
  3. 2023
    Annual accounts 20238,7 k €↓
  4. 2022
    Annual accounts 202253,6 k €↑
  5. 2021
    Annual accounts 202124,5 k €↑
  6. 2020
    Annual accounts 202020,6 k €↓
  7. 2019
    Annual accounts 201922,8 k €↑
  8. 2018
    Annual accounts 201880,5 €↓
  9. 2017
    Annual accounts 20177 k €↓
  10. 2016
    Annual accounts 201671,4 k €↑
  11. 2015
    Annual accounts 2015-7 k €↓
  12. 2014
    Annual accounts 2014884,8 €↓
  13. 2013
    Annual accounts 20132 k €↑
  14. 2012
    Annual accounts 2012135,1 €↓
  15. 2011
    Annual accounts 20115,2 k €↓
  16. 2009
    Annual accounts 200920 k €↑
  17. 2008
    Annual accounts 2008-27,3 k €
  18. 31/05/2007
    IncorporationPrivate limited company